For example, CSD and Cav-BC strongly inhibit the migration of monocytes that migrate well (i.e. TGFβ-treated Normal monocytes and SSc monocytes) and also strongly inhibit Smad 2/3 activation in these cells. Here, TGFB1 is linked to systemic sclerosis.